CN1174772C - Composite medicine for treating cancer of esophagus - Google Patents
Composite medicine for treating cancer of esophagus Download PDFInfo
- Publication number
- CN1174772C CN1174772C CNB02125611XA CN02125611A CN1174772C CN 1174772 C CN1174772 C CN 1174772C CN B02125611X A CNB02125611X A CN B02125611XA CN 02125611 A CN02125611 A CN 02125611A CN 1174772 C CN1174772 C CN 1174772C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight
- radix
- semen
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a composite medicine for treating esophagus cancer, which is formed by preparing raw material medicines, such as walnut meat (rolled into a mud shape), stir-baked SEMEN ARMENIACAE AMARUM, rabdosia, coptis, vietnamese sophora root, figwort root, tendrilleaf fritillary bulb, balloonflower root, nutmeg, common aucklandia root, villous amomum fruit, pagodatree meat (sophora wood ear), scaphium scaphigerum, honeysuckle flower, coix seed, orithyia edulis, garden balsam, borax and raw licorice. The present invention has the functions of promoting blood for dispelling stasis, softening hard lumps and dispelling nodes, regulating qi to eliminate phlegm and reducing fever for benefiting the throat, and has obvious effects on the treatment of esophagus cancer and chronic pharyngitis without toxic or side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of esophageal carcinoma.
Background technology
Esophageal carcinoma, gastric cancer, alimentary tract cancer generally all belong to due to qi stagnation blood stasis, deficiency of both QI and YIN, cloudy gas severe pathogenic cold condense, and in China higher sickness rate are arranged, and people's healthy formation is greatly threatened.When tumor development to a certain degree, when compression esophagus and stomach, often cause block, complication such as dysphagic, vomiting, when serious, under the soup difficulty, this not only brings very big misery to patient, but also because of medicine, food difficulty of transportation influence treatment, patient's body constitution is descended rapidly, cause numerous patient's nutrition to interrupt and generation depletion, so that cause early dead at last.Though the medicine of cancer such as some treatment esophaguses is arranged at present both at home and abroad, and curative effect is all not really desirable.As the logical oral liquid of esophagus, it continues to use ancient prescription, only is made up of three flavor medicines such as Borax, Dai Shi, brain sand, and prescription is simple, and little, the weak curative effect of the property of medicine can not effectively be alleviated esophageal carcinoma and block the also symptom of disease.
Technology contents
The object of the present invention is to provide a kind of energy blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, activating QI to eliminate phlegm, relieving sore-throat by clearing away heat, treatment esophageal carcinoma, chronic pharyngitis are had remarkable result, and the pharmaceutical composition that has no side effect.
The objective of the invention is to be achieved through the following technical solutions:
Choose crude drug:
Semen juglandis (rolling mud) 300-800 weight portion stir-baked SEMEN ARMENIACAE AMARUM 30-90 weight portion
Rabdosia rubescens 30-90 weight portion Rhizoma Coptidis 5-15 weight portion g
Radix Sophorae Tonkinensis 6-18 weight portion Radix Scrophulariae 15-45 weight portion
Bulbus Fritillariae Cirrhosae 15-45 weight portion Radix Platycodonis 15-45 weight portion
KOUREN 4-14 weight portion Radix Aucklandiae 4-14 weight portion
Fructus Amomi 4-14 weight portion Chinese scholartree meat (Auricularia Sophorae) 7-23 weight portion
Semen Sterculiae Lychnophorae 7-23 weight portion Flos Lonicerae 7-23 weight portion
Semen Coicis 15-45 weight portion Pseudobulbus cremastrae seu pleiones 7-23 weight portion
Semen Impatientis 15-45 weight portion Borax 4-14 weight portion
Radix Glycyrrhizae 7-23 weight portion
Optimum ratio of the present invention is:
Choose crude drug:
Semen juglandis (rolling mud) 500 weight portion stir-baked SEMEN ARMENIACAE AMARUMs 60 weight portion Rabdosia rubescens 60 weight portions
Rhizoma Coptidis 10 weight portion Radix Sophorae Tonkinensiss 12 weight portion Radix Scrophulariaes 30 weight portions
Bulbus Fritillariae Cirrhosae 30 weight portion Radix Platycodoniss 30 weight portion KOUREN 9 weight portions
The Radix Aucklandiae 9 weight portion Fructus Amomis 9 weight portion Chinese scholartree meat (Auricularia Sophorae) 15 weight portions
Semen Sterculiae Lychnophorae 15 weight portion Flos Loniceraes 15 weight portion Semen Coiciss 30 weight portions
Pseudobulbus cremastrae seu pleiones 15 weight portion Semen Impatientis 30 weight portion Boraxs 9 weight portions
Radix Glycyrrhizae 15 weight portions
With above-mentioned raw materials medicated powder is fine flour, and practicing honey is ball, adds white sugar 300-800 weight portion when practicing honey, Oleum sesami 50-150 weight portion.The present composition can add three antelope electuaries: Radix Notoginseng powder 30-90 weight portion, Cornu Saigae Tataricae powder 15-45 weight portion, house liyard powder 50-140 weight portion, effect is better.Every ball 9 grams of pill of the present invention, oral, containing, each ball, each 2 grams of three antelope electuaries, day clothes three times.
The present invention was applied to treatment esophageal carcinoma 42 examples in 2002, carcinoma of gastric cardia 23 examples from 1975.Take the present invention's (containing of Semen Juglandis ball), three antelope electuaries, cooperate Chinese medicine decoction, symptom that improvement, alleviation are all arranged.Alleviate back drug withdrawal survival person's 3 examples more than 10 years, person's 2 examples more than 5 years, person's 3 examples more than 3 years, person's 17 examples more than 1 year, half a year above person's 23 examples, 11 routine advanced esophageal cancer patients took medicine after a course of treatment, spirit takes a turn for the better to some extent, but eventually because of the natural drug withdrawal in late period of disease genus.6 way patients far away exceptionally get a course of treatment and do not have message behind the medicine.Effective percentage is 73.9%.
Embodiment:
Get semen juglandis (rolling mud) 500g stir-baked SEMEN ARMENIACAE AMARUM 60g Rabdosia rubescens 60g Rhizoma Coptidis 10g
Radix Sophorae Tonkinensis 12g Radix Scrophulariae 30g Bulbus Fritillariae Cirrhosae 30g Radix Platycodonis 30g
KOUREN 9g Radix Aucklandiae 9g Fructus Amomi 9g Chinese scholartree meat (Auricularia Sophorae) 15g
Semen Sterculiae Lychnophorae 15g Flos Lonicerae 15g Semen Coicis 30g Pseudobulbus cremastrae seu pleiones 15g
Semen Impatientis 30g Borax 9g Radix Glycyrrhizae 15g Radix Notoginseng powder 60g
Cornu Saigae Tataricae powder 30g house liyard powder 90g
With above-mentioned medicine porphyrize powder, dress medium size capsule.
Claims (4)
1, a kind of pharmaceutical composition for the treatment of esophageal carcinoma is characterized in that said composition is to be made by following crude drug:
Semen juglandis 300-800 weight portion stir-baked SEMEN ARMENIACAE AMARUM 30-90 weight portion
Rabdosia rubescens 30-90 weight portion Rhizoma Coptidis 5-15 weight portion
Radix Sophorae Tonkinensis 6-18 weight portion Radix Scrophulariae 15-45 weight portion
Bulbus Fritillariae Cirrhosae 15-45 weight portion Radix Platycodonis 15-45 weight portion
KOUREN 4-14 weight portion Radix Aucklandiae 4-14 weight portion
Fructus Amomi 4-14 weight portion Chinese scholartree meat 7-23 weight portion
Semen Sterculiae Lychnophorae 7-23 weight portion Flos Lonicerae 7-23 weight portion
Semen Coicis 15-45 weight portion Pseudobulbus cremastrae seu pleiones 7-23 weight portion
Semen Impatientis 15-45 weight portion Borax 4-14 weight portion
Radix Glycyrrhizae 7-23 weight portion.
2, pharmaceutical composition according to claim 1 is characterized in that said composition is to be made by following crude drug:
Semen juglandis 500 weight portion stir-baked SEMEN ARMENIACAE AMARUMs 60 weight portion Rabdosia rubescens 60 weight portions
Rhizoma Coptidis 10 weight portion Radix Sophorae Tonkinensiss 12 weight portion Radix Scrophulariaes 30 weight portions
Bulbus Fritillariae Cirrhosae 30 weight portion Radix Platycodoniss 30 weight portion KOUREN 9 weight portions
The Radix Aucklandiae 9 weight portion Fructus Amomis 9 weight portion Chinese scholartree meat 15 weight portions
Semen Sterculiae Lychnophorae 15 weight portion Flos Loniceraes 15 weight portion Semen Coiciss 30 weight portions
Pseudobulbus cremastrae seu pleiones 15 weight portion Semen Impatientis 30 weight portion Boraxs 9 weight portions
Radix Glycyrrhizae 15 weight portions.
3, pharmaceutical composition according to claim 1 is characterized in that also can adding Radix Notoginseng powder 30-90 weight portion, Cornu Saigae Tataricae powder 15-45 weight portion, house liyard powder 50-140 weight portion.
4, drug regimen according to claim 2 is characterized in that adding Radix Notoginseng powder 60 weight portions, Cornu Saigae Tataricae powder 30 weight portions, house liyard powder 90 weight portions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB02125611XA CN1174772C (en) | 2002-07-24 | 2002-07-24 | Composite medicine for treating cancer of esophagus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB02125611XA CN1174772C (en) | 2002-07-24 | 2002-07-24 | Composite medicine for treating cancer of esophagus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1389253A CN1389253A (en) | 2003-01-08 |
CN1174772C true CN1174772C (en) | 2004-11-10 |
Family
ID=4745615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB02125611XA Expired - Fee Related CN1174772C (en) | 2002-07-24 | 2002-07-24 | Composite medicine for treating cancer of esophagus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1174772C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101086037B1 (en) * | 2004-10-27 | 2011-11-22 | 에스케이케미칼주식회사 | Preventive and curative extracts from Sophorae Radix for respiratory organ disease |
CN101700382B (en) * | 2009-11-12 | 2014-12-10 | 张国营 | Cancer pain elimination pill |
CN102114152B (en) * | 2011-03-23 | 2012-02-15 | 许文成 | Medicament for advanced esophageal cancer and preparation method thereof |
CN104800585A (en) * | 2015-05-14 | 2015-07-29 | 奉化科创科技服务有限公司 | Traditional Chinese medicine for treating esophageal cancer |
CN106074997A (en) * | 2016-07-26 | 2016-11-09 | 刘香莉 | A kind of medicament treating esophageal tumor and preparation method thereof |
-
2002
- 2002-07-24 CN CNB02125611XA patent/CN1174772C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1389253A (en) | 2003-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101028407A (en) | Oral Chinese-medicinal composition for treating hyperthyroidism | |
CN103316249B (en) | Astragalus taxus chinensis capsule and preparing process thereof | |
CN1265833C (en) | Chinese medicinal preparation for treating cancer | |
CN103041277B (en) | Traditional Chinese medicine for treating peptic ulcer | |
CN1404853A (en) | Medicine for treating tonsillitis and laryngopharyngitis | |
CN104771647A (en) | Preparation method of traditional Chinese medicine composition for pulmonary tuberculosis treating | |
CN1174772C (en) | Composite medicine for treating cancer of esophagus | |
CN103127366B (en) | Chinese materia medica preparation for treating diabetic heart disease | |
CN102861235B (en) | Health-maintaining preparation made of pure traditional Chinese medicines | |
CN102319352A (en) | Chinese medicinal formula for treating heart disease | |
CN114748583A (en) | Traditional Chinese medicine liquor for nourishing and preserving health | |
CN104707010A (en) | Traditional Chinese medicinal composition for treating pneumonia and clearing away heat and toxic materials and preparation method thereof | |
CN1267141C (en) | Method for preparing compound medicinal capsule and powder for nourishing yin | |
CN105396022A (en) | Preparation method of pharmaceutical tablet alleviating tumor patient radiotherapy reaction | |
CN102671032B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
CN1114885A (en) | External-use medicine powder for health care, nourishing kidney and clearing brain | |
CN103432544B (en) | Decoction for treating upper gastrointestinal hemorrhage | |
CN103110743B (en) | Traditional Chinese medicine composition for treating or preventing neurasthenia and preparation method thereof | |
CN105902766A (en) | Peptic ulcer treating medicine and preparation method thereof | |
CN105853912A (en) | Traditional Chinese medicine composition for treating subacute thyroiditis and preparation method and use thereof | |
CN104984060A (en) | Traditional Chinese medicament for treating coronary heart disease | |
CN113101357A (en) | Medicine for preventing influenza and preparation method thereof | |
CN101219189A (en) | Clinical application of Chinese medicinal herb for treating cancer of the lungs | |
CN1733083A (en) | Menstruation regulating and stomach invigorating pills and its preparation process | |
CN107982481A (en) | A kind of pill medicine for treating gout and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |